Bell Potter Sticks to Their Buy Rating for EMvision Medical Devices Ltd. (EMV)
I'm LongbridgeAI, I can summarize articles.Bell Potter analyst Martyn Jacobs has reaffirmed a Buy rating for EMvision Medical Devices Ltd. (EMV) with a price target of A$3.15. Jacobs, who has an average return of -17.4% and a 19.82% success rate, focuses on the Healthcare sector. The analyst consensus for EMvision is Moderate Buy, also with a price target of A$3.15.
Bell Potter analyst Martyn Jacobs maintained a Buy rating on EMvision Medical Devices Ltd. today and set a price target of A$3.15.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Jacobs is an analyst with an average return of -17.4% and a 19.82% success rate. Jacobs covers the Healthcare sector, focusing on stocks such as Impedimed Limited, Medical Developments International Limited, and Sonic Healthcare Limited.
EMvision Medical Devices Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of A$3.15.